Hi! Sign in or Registration
Looking for Investors
Breathing easier, with help from Israel
Author  Ministry of Foreign Affairs - The State of Israel


Breathing easier, with help from Israel

31 Oct 2010
A robust, portable ventilator from Israel offers extended freedom of movement to sufferers of respiratory conditions.
The Flight 60 portable ventilator from Flight Medical Innovations offers users long-term autonomy.
   The Flight 60 portable ventilator from Flight Medical Innovations offers users long-term autonomy.

By Loren Minsky

Take a moment to appreciate the miracle of each breath. Now take another moment to wonder at the technology that assists those with temporary or chronic breathing conditions. The advent of portable ventilators and the ensuing technological advances that allow them to be used even disconnected from either a fixed power source or compressed air supply have dramatically improved patients' quality of life.


Flight Medical Innovations, based in Lod in central Israel, has been manufacturing cutting-edge portable medical devices for respiratory problems since 1996. Its newly-introduced Flight 60 ventilator offers users their coveted long-term autonomy.

Flight 60 can operate independently for up to 12 hours and thanks to its 'Hot Swap' feature, a replacement battery can be switched in a matter of seconds according to the company. Suitable for infants to adults, the ventilator builds on the features of the company's original HT50 device with additions of the most advanced monitoring and communication features. It measures the actual flow of air to and from the patient, and can be programmed via a touch screen to be accessed locally or remotely, saving time on precautionary visits to the doctor.

The new Flight 60 ventilator. Flight Medical has been offering cutting edge medical devices for respiratory problems since 1996.

Slated to be available this month, the product just received US Food and Drug Administration marketing approval, already has CE approval from the EU, and is seeking regulatory approval in Japan, China and other countries. Products are marketed through local distributors.

Competing against top companies in the field

The original HT50 device was developed by Flight Medical’s R&D division, led by Israeli engineer Carmeli Aduan and assisted by a team of experts in the electronics and software fields.

"Flight Medical came into being at a time when there was an evolution in the market and companies, with the aid of new technology, were able for the first time to produce portable ventilators comparable in many of their capabilities to hospital ventilators mounted on the walls in an ICU," says president and CEO of Flight Medical, Michael Burshtine. It was at this stage that portable ventilators began to come into their own for home care, long-term care, disaster preparedness and transportation of patients.

The 35-employee company is a subsidiary of Medtechnica, Israel’s largest medical equipment distributor. Today it's competing with major international medical equipment companies such as Phillips, CareFusion, Tyco and GE and is well beyond its 'weight category' in terms of its market share in the territories where it operates.

"What takes a year in Israel takes double elsewhere"

With more than 15,000 ventilators sold throughout the world over the past 10 years, Flight Medical’s flagship HT50 ventilator is renowned for its ease of use and critical features, including mandatory, (pre-determined scheduled breaths) as well as the more sophisticated spontaneous ventilation, according to the company.

"You can appreciate the complication if you think of the time frame between the brain’s signal for the need for a breath and the time when such breath is taking place (milliseconds) and the fact that at the same instant the ventilator needs to sense that the patient wants to breathe, build pressure and deliver the air on time," explains Burshtine. The HT50 consumes substantially less power and oxygen than other ventilators on the market, he asserts.

Burshtine believes that Flight Medical's culture of innovation and creativity operates well in an Israeli setting, where he says the company produces exceptional results quickly.

"People here are creative and courageous, willing to venture out of their comfort zone and test new ideas. With portable ventilators there’s a need to combine high-level mechanical engineering with electronic and software capabilities and in Israel there is good interaction between the three. What takes a year to develop in Israel, would take double elsewhere," he says.

The company's vision is to supply every patient with a reliable, easy to use and functionality-rich ventilator. "We're looking to increase our footprint in the 'out-of-hospital' setting, and to expand our reach in medical equipment products. Looking to the future we predict the development of products with a greater degree of sophistication and convergence with other devices found in the patients’ environment," Burshtine concludes.


More Articles of Medical
New Meds Could Stop Cancer by Cutting Off Its Blood
    New Meds Could Stop Cancer by Cutting Off Its Blood    Researchers at Tel Aviv University are developing a new family of medicines that could provide preventive treatment for cancer, or turn existing cancer into a chronic disease that one can live with for years. Details of the study, which was conducted in the laboratory of Dr. Ronit Satchi-Fainaro of the Physiology and Pharmacology Department in the Sackler School of Medicine, will be published in the September 2010 issue of FASEB Journal – the Journal of the Federation of American Societies for Experimental Biology.  Dr. Ronit Satchi-Fainaro  The study is based on the idea that doctors can prevent a cancerous tumor from growing bigger by damaging the process of angiogenesis – the formation of new blood vessels that provide the tumor with oxygen and nutrients.The researchers tested the efficacy of innovative polymeric carriers designed to deliver medicines directly to the cancer cells. In this way, the medicines do not harm healthy tissue and the amount of medicine required is significantly reduced, as are its side effects.The carriers were developed by Dr. Ronit Satchi-Fainaro, Dr. Paula Ofek and colleagues at Berlin University. They were connected to a siRNA-type gene-suppressant and injected into laboratory mice with cancerous tumors. The results were very encouraging: the carriers took the siRNA directly to the cancer cells, and the compound passed through the cell walls and silenced the target genes, without causing the poisoning symptoms that usually accompany cancer treatments.The researchers now hope to do the same thing with siRNA that can silence a gene that plays a key role in angiogenesis.Dr. Satchi-Fainaro said that this kind of treatment could revolutionize cancer therapy. People who are not sick but are at high risk of developing cancer – like former cancer patients or carriers of certain genetic mutations – will be able to receive preventive treatment. In people who have cancer, the medicines will keep the tumor in a state of “hibernation” and turn the cancer into a chronic disease that can be managed for many years, while maintaining a high quality of life.(IsraelNationalNews.com)
Last Articles
Made in Israel - an online exhibition and catalog of Israeli Products & Services made for export
2015 Jun 14
Wanted: Arts majors for high-tech From Globs Technology companies are looking for creativ...
Published by Dafna Barmeli-Golan
Made in Israel - an online exhibition and catalog of Israeli Products & Services made for export
2014 Aug 31
World's biggest fund discovers Tel Aviv From Globs Last year, Rami Levy joined BTI, the g...
Published by Amiram Barkat
Made in Israel - an online exhibition and catalog of Israeli Products & Services made for export
2014 Jul 07
Everyone wins when a big company acquires a start-up. From Globs Exactly three years ago,...
Published by Roy Goldenberg
Made in Israel - an online exhibition and catalog of Israeli Products & Services made for export
2014 Jul 07
Executives in Israel for the MIXiii conference tell "Globes" about the future of medici...
Published by Gali Weinreb